{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:13:17Z","timestamp":1792523597206,"version":"4.5.0"},"reference-count":216,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T00:00:00Z","timestamp":1594771200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009269","name":"Amyloidosis Foundation","doi-asserted-by":"publisher","award":["006075"],"award-info":[{"award-number":["006075"]}],"id":[{"id":"10.13039\/100009269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.ekir.2020.07.013","type":"journal-article","created":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T03:52:22Z","timestamp":1595303542000},"page":"1870-1893","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Understanding Mesangial Pathobiology in AL-Amyloidosis and Monoclonal Ig Light Chain Deposition Disease"],"prefix":"10.1016","volume":"5","author":[{"given":"Guillermo A.","family":"Herrera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamin","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elba A.","family":"Turbat-Herrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"del Pozo-Yauner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ekir.2020.07.013_bib1","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.clml.2019.03.025","article-title":"Multiple myeloma: current advances and future directions","volume":"19","author":"Martin","year":"2019","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.ekir.2020.07.013_bib2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1159\/000442511","article-title":"Current trends of renal impairment in multiple myeloma","volume":"1","author":"Yadav","year":"2016","journal-title":"Kidney Dis (Basel)"},{"key":"10.1016\/j.ekir.2020.07.013_bib3","first-page":"324","article-title":"Monoclonal immunoglobulin light chain-related renal diseases","volume":"13","author":"Sanders","year":"1993","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.ekir.2020.07.013_bib4","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41581-018-0077-4","article-title":"The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group","volume":"15","author":"Leung","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ekir.2020.07.013_bib5","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1182\/blood-2012-07-445304","article-title":"Monoclonal gammopathy of renal significance:when MGUS is no longer undetermined or insignificant","volume":"120","author":"Leung","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ekir.2020.07.013_bib6","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nrneph.2011.168","article-title":"The pathogenesis and diagnosis of acute kidney injury in multiple myeloma","volume":"8","author":"Hutchison","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ekir.2020.07.013_bib7","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/ajh.24738","article-title":"Renal outcomes in patients with AL amyloidosis: prognostic factors, renal response and the impact of therapy","volume":"92","author":"Kastritis","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ekir.2020.07.013_bib8","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.5858\/arpa.2013-0493-OA","article-title":"Proximal tubulopathies associated with monoclonal light chains:the spectrum of clinicopathologic manifestations and molecular pathogenesis","volume":"138","author":"Herrera","year":"2014","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.ekir.2020.07.013_bib9","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.5858\/arpa.2018-0032-OA","article-title":"Tubular injury and dendritic cell activation are integral components of light chain-associated acute tubulointerstitial nephritis","volume":"143","author":"Cheng","year":"2019","journal-title":"Arch Pathol Lab Med"},{"issue":"Suppl 1","key":"10.1016\/j.ekir.2020.07.013_bib10","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/ndt\/14.suppl_1.4","article-title":"The molecular bases of plasma cell dyscrasia-related renal diseases","volume":"14","author":"Ronco","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2020.07.013_bib11","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S1092-9134(00)90042-X","article-title":"Renal manifestations of plasma cell dyscrasias:an appraisal from the patients' bedside to the research laboratory","volume":"4","author":"Herrera","year":"2000","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.ekir.2020.07.013_bib12","first-page":"527","article-title":"Spectrum of glomerular and tubulointerstitial renal lesions associated with monotypical immunoglobulin light chain deposition","volume":"64","author":"Sanders","year":"1991","journal-title":"Lab Invest"},{"key":"10.1016\/j.ekir.2020.07.013_bib13","first-page":"170","article-title":"Ultrastructural immunolabeling in the diagnosis of light-chain-related renal disease","volume":"5","author":"Herrera","year":"1986","journal-title":"Pathol Immunopathol Res"},{"key":"10.1016\/j.ekir.2020.07.013_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s007950100000","article-title":"The contributions of electron microscopy to the understanding and diagnosis of plasma cell dyscrasia-related renal lesions","volume":"34","author":"Herrera","year":"2001","journal-title":"Med Electron Microsc"},{"key":"10.1016\/j.ekir.2020.07.013_bib15","doi-asserted-by":"crossref","first-page":"249","DOI":"10.5858\/133.2.249","article-title":"Renal lesions associated with plasma cell dyscrasias:practical approach to diagnosis, new concepts, and challenges","volume":"133","author":"Herrera","year":"2009","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.ekir.2020.07.013_bib16","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1681\/ASN.2007050532","article-title":"A\u00a0new look at platelet-derived growth factor in renal disease","volume":"19","author":"Floege","year":"2008","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2020.07.013_bib17","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/0046-8177(94)90007-8","article-title":"Growth factors in monoclonal light-chain--related renal diseases","volume":"25","author":"Herrera","year":"1994","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ekir.2020.07.013_bib18","first-page":"375","article-title":"Pathogenesis of glomerulosclerosis in light chain deposition disease. Role for transforming growth factor-beta","volume":"147","author":"Zhu","year":"1995","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ekir.2020.07.013_bib19","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1681\/ASN.V1271482","article-title":"Renal monoclonal immunoglobulin deposition disease:the disease spectrum","volume":"12","author":"Lin","year":"2001","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2020.07.013_bib20","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/nrneph.2018.8","article-title":"Animal models of monoclonal immunoglobulin-related renal diseases","volume":"14","author":"Sirac","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ekir.2020.07.013_bib21","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/s41467-019-09133-w","article-title":"Cryo-EM structure of cardiac amyloid fibrils from an immunoglobulin light chain AL amyloidosis patient","volume":"10","author":"Swuec","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.ekir.2020.07.013_bib22","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1038\/s41598-019-39781-3","article-title":"The CDR1 and other regions of immunoglobulin light chains are hot spots for amyloid aggregation","volume":"9","author":"Ruiz-Zamora","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.ekir.2020.07.013_bib23","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/s41467-019-09032-0","article-title":"Cryo-EM structure of a light chain-derived amyloid fibril from a patient with systemic AL amyloidosis","volume":"10","author":"Radamaker","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.ekir.2020.07.013_bib24","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/cbic.201800732","article-title":"A\u00a0substantial structural conversion of the native monomer leads to in-register parallel amyloid fibril formation in light chain amyloidosis","volume":"20","author":"Lecoq","year":"2019","journal-title":"Chembiochem"},{"key":"10.1016\/j.ekir.2020.07.013_bib25","doi-asserted-by":"crossref","first-page":"19659","DOI":"10.1074\/jbc.RA118.004142","article-title":"Identification of two principal amyloid-driving segments in variable domains of Ig light chains in systemic light-chain amyloidosis","volume":"293","author":"Brumshtein","year":"2018","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.ekir.2020.07.013_bib26","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s12104-016-9718-3","article-title":"Solid-state NMR chemical shift assignments for AL-09 VL immunoglobulin light chain fibrils","volume":"11","author":"Piehl","year":"2017","journal-title":"Biomol NMR Assign"},{"key":"10.1016\/j.ekir.2020.07.013_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181799","article-title":"MAK33 antibody light chain amyloid fibrils are similar to oligomeric precursors","volume":"12","author":"Hora","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ekir.2020.07.013_bib28","series-title":"Experimental Models for Renal Diseases. Pathogenesis and Diagnosis","first-page":"351","article-title":"Glomerular repair: Current status and future expectations","author":"Herrera","year":"2011"},{"key":"10.1016\/j.ekir.2020.07.013_bib29","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3109\/01913123.2013.861568","article-title":"Extrusion of amyloid fibrils to the extracellular space in experimental mesangial AL-amyloidosis:transmission and scanning electron microscopy studies and correlation with renal biopsy observations","volume":"38","author":"Teng","year":"2014","journal-title":"Ultrastruct Pathol"},{"key":"10.1016\/j.ekir.2020.07.013_bib30","first-page":"290","article-title":"In\u00a0vitro AL-amyloid formation by rat and human mesangial cells","volume":"74","author":"Tagouri","year":"1996","journal-title":"Lab Invest"},{"key":"10.1016\/j.ekir.2020.07.013_bib31","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/ki.2014.122","article-title":"An animal model of glomerular light-chain-associated amyloidogenesis depicts the crucial role of lysosomes","volume":"86","author":"Teng","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2020.07.013_bib32","first-page":"485","article-title":"Integrated expression of glomerular extracellular matrix proteins and beta 1 integrins in monoclonal light chain-related renal diseases","volume":"10","author":"Turbat-Herrera","year":"1997","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ekir.2020.07.013_bib33","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000071288","article-title":"Insights into mechanisms responsible for mesangial alterations associated with fibrogenic glomerulopathic light chains","volume":"94","author":"Teng","year":"2003","journal-title":"Nephron Physiol"},{"key":"10.1016\/j.ekir.2020.07.013_bib34","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/ki.2008.504","article-title":"An in\u00a0vitro model of light chain deposition disease","volume":"75","author":"Keeling","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2020.07.013_bib35","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000443282","article-title":"Animal models of light chain deposition disease provide a better understanding of nodular glomerulosclerosis","volume":"132","author":"Herrera","year":"2016","journal-title":"Nephron"},{"key":"10.1016\/j.ekir.2020.07.013_bib36","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1006\/jmbi.1997.1354","article-title":"Standard conformations for the canonical structures of immunoglobulins","volume":"273","author":"Al-Lazikani","year":"1997","journal-title":"J\u00a0Mol Biol"},{"key":"10.1016\/j.ekir.2020.07.013_bib37","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1073\/pnas.79.16.4957","article-title":"Localization of human immunoglobulin kappa light chain variable region genes to the short arm of chromosome 2 by in situ hybridization","volume":"79","author":"Malcolm","year":"1982","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ekir.2020.07.013_bib38","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/nar\/13.2.381","article-title":"Chromosomal orientation of the lambda light chain locus:V lambda is proximal to C lambda in 22q11","volume":"13","author":"Emanuel","year":"1985","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ekir.2020.07.013_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0092-8674(78)90078-8","article-title":"A\u00a0complete immunoglobulin gene is created by somatic recombination","volume":"15","author":"Brack","year":"1978","journal-title":"Cell"},{"key":"10.1016\/j.ekir.2020.07.013_bib40","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.cca.2011.03.007","article-title":"Free immunoglobulin light chain:its biology and implications in diseases","volume":"412","author":"Nakano","year":"2011","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.ekir.2020.07.013_bib41","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3109\/01913129409016277","article-title":"Low molecular weight proteins and the kidney: physiologic and pathologic considerations","volume":"18","author":"Herrera","year":"1994","journal-title":"Ultrastruct Pathol"},{"key":"10.1016\/j.ekir.2020.07.013_bib42","first-page":"F246","article-title":"Myeloma light chains are ligands for cubilin (gp280)","volume":"275","author":"Batuman","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1016\/j.ekir.2020.07.013_bib43","doi-asserted-by":"crossref","first-page":"F562","DOI":"10.1152\/ajprenal.2001.280.4.F562","article-title":"Megalin and cubilin:synergistic endocytic receptors in renal proximal tubule","volume":"280","author":"Christensen","year":"2001","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.ekir.2020.07.013_bib44","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/00041552-199303000-00011","article-title":"Renal involvement in plasma cell dyscrasias","volume":"2","author":"Sanders","year":"1993","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.ekir.2020.07.013_bib45","doi-asserted-by":"crossref","first-page":"4953","DOI":"10.1074\/jbc.M114.615401","article-title":"Differential effects on light chain amyloid formation depend on mutations and type of glycosaminoglycans","volume":"290","author":"Blancas-Mejia","year":"2015","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.ekir.2020.07.013_bib46","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.bpc.2011.05.011","article-title":"Glycosaminoglycans promote fibril formation by amyloidogenic immunoglobulin light chains through a transient interaction","volume":"158","author":"Martin","year":"2011","journal-title":"Biophys Chem"},{"key":"10.1016\/j.ekir.2020.07.013_bib47","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/PL00000706","article-title":"Immunoglobulin light chains, glycosaminoglycans, and amyloid","volume":"57","author":"Stevens","year":"2000","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.ekir.2020.07.013_bib48","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/labinvest.3700161","article-title":"AL-amyloidosis and light-chain deposition disease light chains induce divergent phenotypic transformations of human mesangial cells","volume":"84","author":"Keeling","year":"2004","journal-title":"Lab Invest"},{"key":"10.1016\/j.ekir.2020.07.013_bib49","doi-asserted-by":"crossref","first-page":"7695","DOI":"10.1021\/bi800333s","article-title":"Lipid-derived aldehydes accelerate light chain amyloid and amorphous aggregation","volume":"47","author":"Nieva","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.ekir.2020.07.013_bib50","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/j.bbagen.2018.04.014","article-title":"Localized conformational changes trigger the pH-induced fibrillogenesis of an amyloidogenic lambda light chain protein","volume":"1862","author":"Velazquez-Lopez","year":"2018","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"10.1016\/j.ekir.2020.07.013_bib51","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.bpc.2008.02.019","article-title":"Salts enhance both protein stability and amyloid formation of an immunoglobulin light chain","volume":"135","author":"Sikkink","year":"2008","journal-title":"Biophys Chem"},{"key":"10.1016\/j.ekir.2020.07.013_bib52","first-page":"629","article-title":"Induction in mice of human light-chain-associated amyloidosis","volume":"140","author":"Solomon","year":"1992","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ekir.2020.07.013_bib53","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/13506120701815324","article-title":"Biochemical and aggregation analysis of Bence Jones proteins from different light chain diseases","volume":"15","author":"Sikkink","year":"2008","journal-title":"Amyloid"},{"key":"10.1016\/j.ekir.2020.07.013_bib54","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1074\/jbc.275.3.1570","article-title":"Thermodynamic modulation of light chain amyloid fibril formation","volume":"275","author":"Kim","year":"2000","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.ekir.2020.07.013_bib55","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijms.2016.11.006","article-title":"Oxidative post-translational modifications of an amyloidogenic immunoglobulin light chain protein","volume":"416","author":"Lu","year":"2017","journal-title":"Int J Mass Spectrom"},{"key":"10.1016\/j.ekir.2020.07.013_bib56","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.bpc.2016.10.001","article-title":"Effects of oxidative post-translational modifications on structural stability and self-assembly of lambda6 immunoglobulin light chain","volume":"219","author":"Zottig","year":"2016","journal-title":"Biophys Chem"},{"key":"10.1016\/j.ekir.2020.07.013_bib57","first-page":"189","article-title":"Myeloma light chain cast nephropathy, a review","volume":"32","author":"Sathick","year":"2019","journal-title":"J\u00a0Nephrol"},{"key":"10.1016\/j.ekir.2020.07.013_bib58","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1093\/ndt\/gfq129","article-title":"Crystal-storing histiocytosis with renal Fanconi syndrome: pathological and molecular characteristics compared with classical myeloma-associated Fanconi syndrome","volume":"25","author":"El Hamel","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2020.07.013_bib59","series-title":"Physical Biology of Proteins and Peptides","first-page":"1","article-title":"The structural determinants of the immunoglobulin light chain amyloid aggregation","author":"Del Pozo-Yauner","year":"2015"},{"key":"10.1016\/j.ekir.2020.07.013_bib60","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1006\/jsbi.2000.4248","article-title":"Review:immunoglobulin light chain amyloidosis--the archetype of structural and pathogenic variability","volume":"130","author":"Bellotti","year":"2000","journal-title":"J\u00a0Struct Biol"},{"key":"10.1016\/j.ekir.2020.07.013_bib61","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1126\/science.2658060","article-title":"The role of somatic hypermutation in the generation of antibody diversity","volume":"244","author":"French","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.ekir.2020.07.013_bib62","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1182\/blood-2016-10-743997","article-title":"Clarifying immunoglobulin gene usage in systemic and localized immunoglobulin light-chain amyloidosis by mass spectrometry","volume":"129","author":"Kourelis","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.ekir.2020.07.013_bib63","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1182\/blood-2002-09-2707","article-title":"Immunoglobulin light chain variable (V) region genes influence clinical presentation and outcome in light chain-associated amyloidosis (AL)","volume":"101","author":"Abraham","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ekir.2020.07.013_bib64","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1182\/blood-2002-01-0114","article-title":"Analysis of V(lambda)-J(lambda) expression in plasma cells from primary (AL) amyloidosis and normal bone marrow identifies 3r (lambdaIII) as a new amyloid-associated germline gene segment","volume":"100","author":"Perfetti","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.ekir.2020.07.013_bib65","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1182\/blood.V98.3.714","article-title":"The tropism of organ involvement in primary systemic amyloidosis: contributions of Ig V(L) germ line gene use and clonal plasma cell burden","volume":"98","author":"Comenzo","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.ekir.2020.07.013_bib66","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1046\/j.1365-2141.1999.01591.x","article-title":"Clonal immunoglobulin light chain variable region germline gene use in AL amyloidosis:association with dominant amyloid-related organ involvement and survival after stem cell transplantation","volume":"106","author":"Comenzo","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ekir.2020.07.013_bib67","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1006\/clin.1994.1070","article-title":"Preferential expression of human lambda-light-chain variable-region subgroups in multiple myeloma, AL amyloidosis, and Waldenstrom's macroglobulinemia","volume":"71","author":"Ozaki","year":"1994","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.ekir.2020.07.013_bib68","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/prot.21934","article-title":"Influence of the germline sequence on the thermodynamic stability and fibrillogenicity of human lambda 6 light chains","volume":"72","author":"del Pozo Yauner","year":"2008","journal-title":"Proteins"},{"key":"10.1016\/j.ekir.2020.07.013_bib69","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1172\/JCI110635","article-title":"Bence Jones proteins and light chains of immunoglobulins. Preferential association of the V lambda VI subgroup of human light chains with amyloidosis AL (lambda)","volume":"70","author":"Solomon","year":"1982","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ekir.2020.07.013_bib70","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1515\/hsz-2016-0178","article-title":"Stability and aggregation propensity do not fully account for the association of various germline variable domain gene segments with light chain amyloidosis","volume":"398","author":"Garay Sanchez","year":"2017","journal-title":"Biol Chem"},{"key":"10.1016\/j.ekir.2020.07.013_bib71","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0165-2478(94)90036-1","article-title":"Overrepresentation of the V kappa IV subgroup in light chain deposition disease","volume":"42","author":"Denoroy","year":"1994","journal-title":"Immunol Lett"},{"key":"10.1016\/j.ekir.2020.07.013_bib72","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1016\/S0002-9440(10)65520-4","article-title":"Somatic mutations of the L12a gene in V-kappa(1) light chain deposition disease:potential effects on aberrant protein conformation and deposition","volume":"155","author":"Vidal","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ekir.2020.07.013_bib73","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0002-9440(10)65573-3","article-title":"Complete primary sequences of two lambda immunoglobulin light chains in myelomas with nonamyloid (Randall-type) light chain deposition disease","volume":"153","author":"Decourt","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ekir.2020.07.013_bib74","doi-asserted-by":"crossref","first-page":"10664","DOI":"10.1039\/C8CC04396E","article-title":"Immunoglobulin light chain amyloid aggregation","volume":"54","author":"Blancas-Mejia","year":"2018","journal-title":"Chem Commun (Camb)"},{"key":"10.1016\/j.ekir.2020.07.013_bib75","doi-asserted-by":"crossref","first-page":"16809","DOI":"10.1038\/s41598-017-16953-7","article-title":"Concurrent structural and biophysical traits link with immunoglobulin light chains amyloid propensity","volume":"7","author":"Oberti","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.ekir.2020.07.013_bib76","doi-asserted-by":"crossref","first-page":"13039","DOI":"10.1074\/jbc.A114.629550","article-title":"Site-directed mutagenesis reveals regions implicated in the stability and fiber formation of human lambda3r light chains","volume":"290","author":"Villalba","year":"2015","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.ekir.2020.07.013_bib77","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.bbrc.2013.11.123","article-title":"The N-terminal strand modulates immunoglobulin light chain fibrillogenesis","volume":"443","author":"del Pozo-Yauner","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ekir.2020.07.013_bib78","doi-asserted-by":"crossref","first-page":"6173","DOI":"10.1111\/febs.12538","article-title":"Mutational and genetic determinants of lambda6 light chain amyloidogenesis","volume":"280","author":"Gonzalez-Andrade","year":"2013","journal-title":"FEBS J"},{"key":"10.1016\/j.ekir.2020.07.013_bib79","doi-asserted-by":"crossref","first-page":"e5169","DOI":"10.1371\/journal.pone.0005169","article-title":"Mutations in specific structural regions of immunoglobulin light chains are associated with free light chain levels in patients with AL amyloidosis","volume":"4","author":"Poshusta","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.ekir.2020.07.013_bib80","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1006\/jmbi.2001.5092","article-title":"Both the environment and somatic mutations govern the aggregation pathway of pathogenic immunoglobulin light chain","volume":"313","author":"Davis","year":"2001","journal-title":"J\u00a0Mol Biol"},{"key":"10.1016\/j.ekir.2020.07.013_bib81","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jmb.2009.11.038","article-title":"A\u00a0single mutation at the sheet switch region results in conformational changes favoring lambda6 light-chain fibrillogenesis","volume":"396","author":"Hernandez-Santoyo","year":"2010","journal-title":"J\u00a0Mol Biol"},{"key":"10.1016\/j.ekir.2020.07.013_bib82","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1073\/pnas.91.12.5446","article-title":"A\u00a0role for destabilizing amino acid replacements in light-chain amyloidosis","volume":"91","author":"Hurle","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ekir.2020.07.013_bib83","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1002\/pro.2790","article-title":"Mutations can cause light chains to be too stable or too unstable to form amyloid fibrils","volume":"24","author":"Marin-Argany","year":"2015","journal-title":"Protein Sci"},{"key":"10.1016\/j.ekir.2020.07.013_bib84","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1002\/pro.2730","article-title":"Effect of single point mutations in a form of systemic amyloidosis","volume":"24","author":"Bhavaraju","year":"2015","journal-title":"Protein Sci"},{"key":"10.1016\/j.ekir.2020.07.013_bib85","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1006\/jmbi.1996.0148","article-title":"Specificity of abnormal assembly in immunoglobulin light chain deposition disease and amyloidosis","volume":"257","author":"Helms","year":"1996","journal-title":"J\u00a0Mol Biol"},{"key":"10.1016\/j.ekir.2020.07.013_bib86","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1110\/ps.8.3.509","article-title":"Physicochemical consequences of amino acid variations that contribute to fibril formation by immunoglobulin light chains","volume":"8","author":"Raffen","year":"1999","journal-title":"Protein Sci"},{"key":"10.1016\/j.ekir.2020.07.013_bib87","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1038\/srep01278","article-title":"Role of\u00a0mutations in the cellular internalization of amyloidogenic light chains into cardiomyocytes","volume":"3","author":"Levinson","year":"2013","journal-title":"Sci Rep"},{"key":"10.1016\/j.ekir.2020.07.013_bib88","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.ajpath.2010.11.044","article-title":"Family portrait:renal progenitor of Bowman's capsule and its tubular brothers","volume":"178","author":"Romagnani","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ekir.2020.07.013_bib89","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1021\/bi061716v","article-title":"Structural characterization of the partially folded intermediates of an immunoglobulin light chain leading to amyloid fibrillation and amorphous aggregation","volume":"46","author":"Qin","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.ekir.2020.07.013_bib90","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jmb.2013.10.016","article-title":"Kinetic control in protein folding for light chain amyloidosis and the differential effects of somatic mutations","volume":"426","author":"Blancas-Mejia","year":"2014","journal-title":"J\u00a0Mol Biol"},{"key":"10.1016\/j.ekir.2020.07.013_bib91","doi-asserted-by":"crossref","first-page":"10339","DOI":"10.1038\/s41598-017-10906-w","article-title":"Effect of amino acid mutations on the conformational dynamics of amyloidogenic immunoglobulin light-chains: a combined NMR and in silico study","volume":"7","author":"Mukherjee","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.ekir.2020.07.013_bib92","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.52300","article-title":"Fatal amyloid formation in a patient's antibody light chain is caused by a single point mutation","volume":"9","author":"Kazman","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.ekir.2020.07.013_bib93","doi-asserted-by":"crossref","first-page":"30950","DOI":"10.1074\/jbc.M804822200","article-title":"Structural insights into the role of mutations in amyloidogenesis","volume":"283","author":"Baden","year":"2008","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.ekir.2020.07.013_bib94","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.bbapap.2016.01.009","article-title":"Probing the role of lambda6 immunoglobulin light chain dimerization in amyloid formation","volume":"1864","author":"Wolwertz","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ekir.2020.07.013_bib95","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1016\/j.bbadis.2017.12.009","article-title":"Structure and energetic basis of overrepresented lambda light chain in systemic light chain amyloidosis patients","volume":"1864","author":"Zhao","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.ekir.2020.07.013_bib96","doi-asserted-by":"crossref","first-page":"12666","DOI":"10.1074\/jbc.M109229200","article-title":"Elucidation of the molecular mechanism during the early events in immunoglobulin light chain amyloid fibrillation. Evidence for an off-pathway oligomer at acidic pH","volume":"277","author":"Souillac","year":"2002","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.ekir.2020.07.013_bib97","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1042\/bse0560011","article-title":"The physical chemistry of the amyloid phenomenon:thermodynamics and kinetics of filamentous protein aggregation","volume":"56","author":"Buell","year":"2014","journal-title":"Essays Biochem"},{"key":"10.1016\/j.ekir.2020.07.013_bib98","doi-asserted-by":"crossref","first-page":"4280","DOI":"10.1016\/j.jmb.2016.08.021","article-title":"The kinetic stability of a full-length antibody light chain dimer determines whether endoproteolysis can release amyloidogenic variable domains","volume":"428","author":"Morgan","year":"2016","journal-title":"J\u00a0Mol Biol"},{"key":"10.1016\/j.ekir.2020.07.013_bib99","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1093\/protein\/10.10.1191","article-title":"Molecular modeling of immunoglobulin light chains implicates hydrophobic residues in non-amyloid light chain deposition disease","volume":"10","author":"Deret","year":"1997","journal-title":"Protein Eng"},{"key":"10.1016\/j.ekir.2020.07.013_bib100","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1021\/bi001782b","article-title":"Partially folded intermediates as critical precursors of light chain amyloid fibrils and amorphous aggregates","volume":"40","author":"Khurana","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.ekir.2020.07.013_bib101","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/jmr.681","article-title":"Structural basis of light chain amyloidogenicity: comparison of the thermodynamic properties, fibrillogenic potential and tertiary structural features of four Vlambda6 proteins","volume":"17","author":"Wall","year":"2004","journal-title":"J\u00a0Mol Recognit"},{"key":"10.1016\/j.ekir.2020.07.013_bib102","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1074\/jbc.M007766200","article-title":"Counteracting effects of renal solutes on amyloid fibril formation by immunoglobulin light chains","volume":"276","author":"Kim","year":"2001","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.ekir.2020.07.013_bib103","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.jmb.2008.12.069","article-title":"Thermodynamic and kinetic characterization of a germ line human lambda6 light-chain protein:the relation between unfolding and fibrillogenesis","volume":"386","author":"Blancas-Mejia","year":"2009","journal-title":"J\u00a0Mol Biol"},{"key":"10.1016\/j.ekir.2020.07.013_bib104","doi-asserted-by":"crossref","first-page":"14101","DOI":"10.1021\/bi991131j","article-title":"Thermodynamic instability of human lambda 6 light chains:correlation with fibrillogenicity","volume":"38","author":"Wall","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/j.ekir.2020.07.013_bib105","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.2174\/1568026611212220007","article-title":"Amyloid formation in light chain amyloidosis","volume":"12","author":"Ramirez-Alvarado","year":"2012","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.ekir.2020.07.013_bib106","doi-asserted-by":"crossref","first-page":"27240","DOI":"10.1074\/jbc.M202492200","article-title":"Kinetics and energetics of assembly, nucleation, and growth of aggregates and fibrils for an amyloidogenic protein. Insights into transition states from pressure, temperature, and co-solute studies","volume":"277","author":"Kim","year":"2002","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.ekir.2020.07.013_bib107","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.jmb.2009.07.075","article-title":"The folding pathway of the antibody V(L) domain","volume":"392","author":"Simpson","year":"2009","journal-title":"J\u00a0Mol Biol"},{"key":"10.1016\/j.ekir.2020.07.013_bib108","doi-asserted-by":"crossref","first-page":"8066","DOI":"10.1021\/ja302598j","article-title":"Real-time NMR characterization of structure and dynamics in a transiently populated protein folding intermediate","volume":"134","author":"Rennella","year":"2012","journal-title":"J\u00a0Am Chem Soc"},{"key":"10.1016\/j.ekir.2020.07.013_bib109","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nsmb1058","article-title":"Amyloid formation under physiological conditions proceeds via a native-like folding intermediate","volume":"13","author":"Jahn","year":"2006","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.ekir.2020.07.013_bib110","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1126\/science.1214203","article-title":"Structure of an intermediate state in protein folding and aggregation","volume":"336","author":"Neudecker","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.ekir.2020.07.013_bib111","doi-asserted-by":"crossref","first-page":"8665","DOI":"10.1021\/bi800806d","article-title":"Effect of methionine oxidation on the structural properties, conformational stability, and aggregation of immunoglobulin light chain LEN","volume":"47","author":"Hu","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.ekir.2020.07.013_bib112","doi-asserted-by":"crossref","first-page":"7085","DOI":"10.1021\/acsomega.9b03220","article-title":"Site-specific interactions with copper promote amyloid fibril formation for lambda6aJL2-R24G","volume":"5","author":"Pelaez-Aguilar","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.ekir.2020.07.013_bib113","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1110\/ps.051997606","article-title":"The effects of sodium sulfate, glycosaminoglycans, and Congo red on the structure, stability, and amyloid formation of an immunoglobulin light-chain protein","volume":"15","author":"McLaughlin","year":"2006","journal-title":"Protein Sci"},{"key":"10.1016\/j.ekir.2020.07.013_bib114","doi-asserted-by":"crossref","first-page":"16672","DOI":"10.1073\/pnas.0505905102","article-title":"The\u00a0amyloid\u00a0stretch hypothesis: recruiting proteins toward\u00a0the\u00a0dark side","volume":"102","author":"Esteras-Chopo","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ekir.2020.07.013_bib115","doi-asserted-by":"crossref","first-page":"13562","DOI":"10.1021\/jacs.9b05499","article-title":"The role of protein thermodynamics and primary structure in fibrillogenesis of variable domains from immunoglobulin light chains","volume":"141","author":"Rennella","year":"2019","journal-title":"J\u00a0Am Chem Soc"},{"key":"10.1016\/j.ekir.2020.07.013_bib116","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1096\/fj.201701183RR","article-title":"Evidence for a central role of PrP helix 2 in the nucleation of amyloid fibrils","volume":"32","author":"Honda","year":"2018","journal-title":"FASEB J"},{"key":"10.1016\/j.ekir.2020.07.013_bib117","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1021\/acs.biochem.6b01120","article-title":"Heparin and methionine oxidation promote the formation of apolipoprotein A-I amyloid comprising alpha-helical and beta-sheet structures","volume":"56","author":"Townsend","year":"2017","journal-title":"Biochemistry"},{"key":"10.1016\/j.ekir.2020.07.013_bib118","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00249-017-1235-5","article-title":"Impact of a discordant helix on beta-amyloid structure, aggregation ability and toxicity","volume":"46","author":"Chen","year":"2017","journal-title":"Eur Biophys J"},{"key":"10.1016\/j.ekir.2020.07.013_bib119","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3109\/13506129.2014.980943","article-title":"The Arctic mutation accelerates Abeta aggregation in SDS through reducing the helical propensity of residues 15\u201325","volume":"22","author":"Lo","year":"2015","journal-title":"Amyloid"},{"key":"10.1016\/j.ekir.2020.07.013_bib120","doi-asserted-by":"crossref","first-page":"204","DOI":"10.4103\/ijn.IJN_36_18","article-title":"Coexistent amyloid fibrils in a patient with combined light chain deposition disease and light chain cast nephropathy","volume":"29","author":"Anandh","year":"2019","journal-title":"Indian J Nephrol"},{"key":"10.1016\/j.ekir.2020.07.013_bib121","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1182\/blood-2015-11-681650","article-title":"Beyond the plasma cell:emerging therapies for immunoglobulin light chain amyloidosis","volume":"127","author":"Weiss","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.ekir.2020.07.013_bib122","first-page":"116","article-title":"The mesangium as target for glomerulopathic light and heavy chains: pathogenic considerations in light and heavy chain-mediated glomerular damage","volume":"Vol. 153","author":"Keeling","year":"2007"},{"key":"10.1016\/j.ekir.2020.07.013_bib123","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/00041552-200305000-00001","article-title":"The potential for regression of renal scarring","volume":"12","author":"Fogo","year":"2003","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.ekir.2020.07.013_bib124","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/019131299281752","article-title":"Glomerulopathic light chain-mesangial cell interactions modulate in\u00a0vitro extracellular matrix remodeling and reproduce mesangiopathic findings documented in\u00a0vivo","volume":"23","author":"Herrera","year":"1999","journal-title":"Ultrastruct Pathol"},{"key":"10.1016\/j.ekir.2020.07.013_bib125","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/labinvest.3700069","article-title":"Different types of glomerulopathic light chains interact with mesangial cells using a common receptor but exhibit different intracellular trafficking patterns","volume":"84","author":"Teng","year":"2004","journal-title":"Lab Invest"},{"key":"10.1016\/j.ekir.2020.07.013_bib126","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00125480-200401000-00005","article-title":"Dysproteinemia and the kidney","volume":"11","author":"Markowitz","year":"2004","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.ekir.2020.07.013_bib127","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1186\/s12967-019-02147-4","article-title":"The pathogenesis of renal injury and treatment in light chain deposition disease","volume":"17","author":"Wang","year":"2019","journal-title":"J\u00a0Transl Med"},{"key":"10.1016\/j.ekir.2020.07.013_bib128","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1751-553X.2012.01419.x","article-title":"Light chain deposition disease: novel biological insights and treatment advances","volume":"34","author":"Jimenez-Zepeda","year":"2012","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.ekir.2020.07.013_bib129","doi-asserted-by":"crossref","first-page":"100581","DOI":"10.1016\/j.blre.2019.05.005","article-title":"Use of novel therapies in the treatment of light chain amyloidosis","volume":"37","author":"Varga","year":"2019","journal-title":"Blood Rev"},{"key":"10.1016\/j.ekir.2020.07.013_bib130","doi-asserted-by":"crossref","first-page":"176","DOI":"10.2215\/CJN.06100616","article-title":"Renal toxicities of novel agents used for treatment of multiple myeloma","volume":"12","author":"Wanchoo","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2020.07.013_bib131","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1681\/ASN.V210s74","article-title":"The mesangial phagocyte and its regulation of contractile cell biology","volume":"2","author":"Schreiner","year":"1992","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2020.07.013_bib132","first-page":"437","article-title":"The danger control concept in kidney disease: mesangial cells","volume":"26","author":"Migliorini","year":"2013","journal-title":"J\u00a0Nephrol"},{"key":"10.1016\/j.ekir.2020.07.013_bib133","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1080\/01913120600932594","article-title":"Plasticity of mesangial cells: a basis for understanding pathological alterations","volume":"30","author":"Herrera","year":"2006","journal-title":"Ultrastruct Pathol"},{"key":"10.1016\/j.ekir.2020.07.013_bib134","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1681\/ASN.2008050549","article-title":"The mesangial cell revisited:no cell is an island","volume":"20","author":"Schlondorff","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2020.07.013_bib135","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1179\/his.1996.19.3.219","article-title":"Silver stains in diagnostic renal pathology","volume":"19","author":"Herrera","year":"1996","journal-title":"J\u00a0Histotechnol"},{"key":"10.1016\/j.ekir.2020.07.013_bib136","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/labinvest.3780278","article-title":"Monoclonal light chain--mesangial cell interactions:early signaling events and subsequent pathologic effects","volume":"81","author":"Russell","year":"2001","journal-title":"Lab Invest"},{"key":"10.1016\/j.ekir.2020.07.013_bib137","first-page":"13","article-title":"Mesenchymal stem cells in mesangial repair in a model of immunoglobulin light-chain mediated mesangial injury","volume":"4","author":"Herrera","year":"2014","journal-title":"J\u00a0Stem Cell Res Ther"},{"key":"10.1016\/j.ekir.2020.07.013_bib138","series-title":"XIth International Symposium on Amyloidosis","first-page":"307","article-title":"Mesangial amyloid formation in an isolated rat kidney perfusion model: a new model to study renal amyloidogenesis","author":"Herrera","year":"2007"},{"key":"10.1016\/j.ekir.2020.07.013_bib139","first-page":"003","article-title":"Understanding mesangial damage and repair: insights from an experimental model of immunoglobulin light chain-associated mesangiopathy","volume":"1","author":"Herrera","year":"2014","journal-title":"J\u00a0Cell Biol Cell Metab"},{"key":"10.1016\/j.ekir.2020.07.013_bib140","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1111\/j.1523-1755.2005.00571.x","article-title":"Matrix metalloproteinases and mesangial remodeling in light chain-related glomerular damage","volume":"68","author":"Keeling","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2020.07.013_bib141","doi-asserted-by":"crossref","first-page":"6560","DOI":"10.1073\/pnas.88.15.6560","article-title":"Platelet-derived growth factor (PDGF) and PDGF receptor are induced in mesangial proliferative nephritis in the rat","volume":"88","author":"Iida","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ekir.2020.07.013_bib142","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0002-9440(10)64121-1","article-title":"Increased glomerular and tubular expression of transforming growth factor-beta1, its type II receptor, and activation of the Smad signaling pathway in the db\/db mouse","volume":"158","author":"Hong","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ekir.2020.07.013_bib143","doi-asserted-by":"crossref","first-page":"C1595","DOI":"10.1152\/ajpcell.1996.270.6.C1595","article-title":"TNF-alpha and IL-1 alpha induce mannose receptors and apoptosis in glomerular mesangial but not endothelial cells","volume":"270","author":"Liu","year":"1996","journal-title":"Am J Physiol"},{"key":"10.1016\/j.ekir.2020.07.013_bib144","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1681\/ASN.V94568","article-title":"Mesangial cells possess an asialoglycoprotein receptor with affinity for human immunoglobulin A","volume":"9","author":"Gomez-Guerrero","year":"1998","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2020.07.013_bib145","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s11010-012-1406-8","article-title":"Response of VEGF to activation of viral receptors and TNFalpha in human mesangial cells","volume":"370","author":"Merkle","year":"2012","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.ekir.2020.07.013_bib146","first-page":"S86","article-title":"Integrin matrix receptors in renal injury","volume":"45","author":"Adler","year":"1994","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.ekir.2020.07.013_bib147","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1152\/physrev.00046.2003","article-title":"Role of caveolae and caveolins in health and disease","volume":"84","author":"Cohen","year":"2004","journal-title":"Physiol Rev"},{"key":"10.1016\/j.ekir.2020.07.013_bib148","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1146\/annurev.biochem.67.1.199","article-title":"The caveolae membrane system","volume":"67","author":"Anderson","year":"1998","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.ekir.2020.07.013_bib149","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1091\/mbc.01-06-0317","article-title":"Caveolae are highly immobile plasma membrane microdomains, which are not involved in constitutive endocytic trafficking","volume":"13","author":"Thomsen","year":"2002","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.ekir.2020.07.013_bib150","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3109\/13506129809007296","article-title":"In\u00a0vitro modulation of AL-amyloid formation by human mesangial cells exposed to amyloidogenic light chains","volume":"5","author":"Isaac","year":"1998","journal-title":"Amyloid"},{"key":"10.1016\/j.ekir.2020.07.013_bib151","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1007\/s00018-018-2752-9","article-title":"Analysis of novel endosome-to-Golgi retrieval genes reveals a role for PLD3 in regulating endosomal protein sorting and amyloid precursor protein processing","volume":"75","author":"Mukadam","year":"2018","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.ekir.2020.07.013_bib152","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.287.5454.816","article-title":"Perspectives: drug delivery. Regulating export of ER cargo","volume":"287","author":"Aridor","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.ekir.2020.07.013_bib153","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1126\/science.287.5454.826","article-title":"Regulation of protein secretion through controlled aggregation in the endoplasmic reticulum","volume":"287","author":"Rivera","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.ekir.2020.07.013_bib154","first-page":"107","article-title":"Formation of \u201camyloid\u201d fibrils in\u00a0vitro by action of human kidney lysosomal enzymes on Bence Jones proteins","volume":"84","author":"Epstein","year":"1974","journal-title":"J\u00a0Lab Clin Med"},{"key":"10.1016\/j.ekir.2020.07.013_bib155","doi-asserted-by":"crossref","first-page":"a024323","DOI":"10.1101\/cshperspect.a024323","article-title":"Noncerebral amyloidoses:aspects on seeding, cross-seeding, and transmission","volume":"8","author":"Westermark","year":"2018","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.ekir.2020.07.013_bib156","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00726-001-0113-7","article-title":"Modeling Alzheimer's disease and other proteopathies in\u00a0vivo: is seeding the key?","volume":"23","author":"Walker","year":"2002","journal-title":"Amino Acids"},{"key":"10.1016\/j.ekir.2020.07.013_bib157","doi-asserted-by":"crossref","first-page":"100937","DOI":"10.1016\/j.arr.2019.100937","article-title":"Amyloid cross-seeding raises new dimensions to understanding of amyloidogenesis mechanism","volume":"56","author":"Chaudhuri","year":"2019","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.ekir.2020.07.013_bib158","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/jemt.20565","article-title":"Human matrix metalloproteinases: characteristics and pathologic role in altering mesangial homeostasis","volume":"71","author":"Keeling","year":"2008","journal-title":"Microsc Res Tech"},{"key":"10.1016\/j.ekir.2020.07.013_bib159","first-page":"10","article-title":"Protein chemistry of amyloid fibrils and chaperones:implications for amyloid formation and disease","volume":"4","author":"Yerbury","year":"2010","journal-title":"Current Chemical Biology"},{"key":"10.1016\/j.ekir.2020.07.013_bib160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1110\/ps.04887005","article-title":"Amyloid accomplices and enforcers","volume":"14","author":"Alexandrescu","year":"2005","journal-title":"Protein Sci"},{"key":"10.1016\/j.ekir.2020.07.013_bib161","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1134\/S0006297906070029","article-title":"Role of ApoE in conformation-prone diseases and atherosclerosis","volume":"71","author":"Dergunov","year":"2006","journal-title":"Biochemistry (Mosc)"},{"issue":"Suppl 4","key":"10.1016\/j.ekir.2020.07.013_bib162","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/nep.13461","article-title":"Complement in glomerular diseases","volume":"23","author":"Tan","year":"2018","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.ekir.2020.07.013_bib163","doi-asserted-by":"crossref","first-page":"4590","DOI":"10.4049\/jimmunol.163.8.4590","article-title":"Nephritogenic lambda light chain dimer:a unique human miniautoantibody against complement factor H","volume":"163","author":"Jokiranta","year":"1999","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.ekir.2020.07.013_bib164","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.kint.2017.04.039","article-title":"Complement-dependent, monoclonal gammapathy-associated thrombotic microangiopathy","volume":"92","author":"Schurder","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2020.07.013_bib165","first-page":"16","article-title":"Sortilin-related receptor (SORL-1) mediates glomerulopathic light chain interactions with mesangial cells. Proceedings of the American Society Nephrology Meeting, San Diego, CA","volume":"29","author":"Herrera","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2020.07.013_bib166","first-page":"157","article-title":"Cerebrovascular smooth muscle cells internalize Alzheimer amyloid beta protein via a lipoprotein pathway:implications for cerebral amyloid angiopathy","volume":"77","author":"Urmoneit","year":"1997","journal-title":"Lab Invest"},{"key":"10.1016\/j.ekir.2020.07.013_bib167","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s12185-016-2112-1","article-title":"Phase 2 trial of daily, oral epigallocatechin gallate in patients with light-chain amyloidosis","volume":"105","author":"Meshitsuka","year":"2017","journal-title":"Int J Hematol"},{"key":"10.1016\/j.ekir.2020.07.013_bib168","doi-asserted-by":"crossref","first-page":"4978","DOI":"10.1021\/acs.biochem.5b00288","article-title":"Inhibition of Light Chain 6aJL2-R24G amyloid fiber formation associated with light chain amyloidosis","volume":"54","author":"Pelaez-Aguilar","year":"2015","journal-title":"Biochemistry"},{"key":"10.1016\/j.ekir.2020.07.013_bib169","first-page":"15","article-title":"Epigallocatechin-3-gallate inhibits renal light chain amyloidogenesis by two different mechanisms [abstract]","volume":"Vol. 99","author":"Herrera","year":"2019"},{"key":"10.1016\/j.ekir.2020.07.013_bib170","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1152\/physrev.00059.2009","article-title":"Role of Rab GTPases in membrane traffic and cell physiology","volume":"91","author":"Hutagalung","year":"2011","journal-title":"Physiol Rev"},{"key":"10.1016\/j.ekir.2020.07.013_bib171","doi-asserted-by":"crossref","first-page":"jcs216499","DOI":"10.1242\/jcs.216499","article-title":"The enigmatic endosome - sorting the ins and outs of endocytic trafficking","volume":"131","author":"Naslavsky","year":"2018","journal-title":"J\u00a0Cell Sci"},{"key":"10.1016\/j.ekir.2020.07.013_bib172","doi-asserted-by":"crossref","first-page":"12345","DOI":"10.1021\/bi00164a008","article-title":"Amyloid fibril formation requires a chemically discriminating nucleation event:studies of an amyloidogenic sequence from the bacterial protein OsmB","volume":"31","author":"Jarrett","year":"1992","journal-title":"Biochemistry"},{"key":"10.1016\/j.ekir.2020.07.013_bib173","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1006\/jsbi.2000.4264","article-title":"Amyloid fibril formation and seeding by wild-type human lysozyme and its disease-related mutational variants","volume":"130","author":"Morozova-Roche","year":"2000","journal-title":"J\u00a0Struct Biol"},{"key":"10.1016\/j.ekir.2020.07.013_bib174","doi-asserted-by":"crossref","first-page":"9848","DOI":"10.1021\/bi101351c","article-title":"The critical role of the constant region in thermal stability and aggregation of amyloidogenic immunoglobulin light chain","volume":"49","author":"Klimtchuk","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.ekir.2020.07.013_bib175","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bpc.2015.07.005","article-title":"Thermodynamic and fibril formation studies of full length immunoglobulin light chain AL-09 and its germline protein using scan rate dependent thermal unfolding","volume":"207","author":"Blancas-Mejia","year":"2015","journal-title":"Biophys Chem"},{"key":"10.1016\/j.ekir.2020.07.013_bib176","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0019-2791(72)90278-9","article-title":"Polymer formation during the degradation of human light chain and Bence-Jones proteins by an extrct of the lysosomal fraction of normal human kidney","volume":"9","author":"Tan","year":"1972","journal-title":"Immunochemistry"},{"key":"10.1016\/j.ekir.2020.07.013_bib177","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1080\/01913123.2017.1349852","article-title":"Contribution of human smooth muscle cells to amyloid angiopathy in AL (light-chain) amyloidosis","volume":"41","author":"Vora","year":"2017","journal-title":"Ultrastruct Pathol"},{"key":"10.1016\/j.ekir.2020.07.013_bib178","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1681\/ASN.2006030218","article-title":"Regrow or repair: potential regenerative therapies for the kidney","volume":"17","author":"Little","year":"2006","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2020.07.013_bib179","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0002-9440(10)63683-8","article-title":"Bone-marrow-derived cells contribute to glomerular endothelial repair in experimental glomerulonephritis","volume":"163","author":"Rookmaaker","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ekir.2020.07.013_bib180","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jfma.2013.12.001","article-title":"Stem cells and kidney regeneration","volume":"113","author":"Chou","year":"2014","journal-title":"J\u00a0Formos Med Assoc"},{"key":"10.1016\/j.ekir.2020.07.013_bib181","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3109\/01913123.2016.1145776","article-title":"Healing the damaged mesangium in nodular glomerulosclerosis using mesenchymal stem cells (MSCs):Expectations and challenges","volume":"40","author":"Herrera","year":"2016","journal-title":"Ultrastruct Pathol"},{"key":"10.1016\/j.ekir.2020.07.013_bib182","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/ki.2014.32","article-title":"Report on ISN Forefronts, Florence, Italy, 12\u201315 September. 2013: Stem cells and kidney regeneration","volume":"86","author":"Romagnani","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2020.07.013_bib183","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1080\/01913123.2018.1449772","article-title":"Phenotypic plasticity of mesenchymal stem cells is crucial for mesangial repair in a model of immunoglobulin light chain-associated mesangial damage","volume":"42","author":"Herrera","year":"2018","journal-title":"Ultrastruct Pathol"},{"key":"10.1016\/j.ekir.2020.07.013_bib184","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1080\/00313020701716367","article-title":"Differentiation of human mesenchymal stem cells into mesangial cells in post-glomerular injury murine model","volume":"40","author":"Wong","year":"2008","journal-title":"Pathology"},{"key":"10.1016\/j.ekir.2020.07.013_bib185","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/cbin.10231","article-title":"In\u00a0vitro differentiation of mesenchymal stem cells into mesangial cells when co-cultured with injured mesangial cells","volume":"38","author":"Wong","year":"2014","journal-title":"Cell Biol Int"},{"key":"10.1016\/j.ekir.2020.07.013_bib186","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ajpath.2013.04.024","article-title":"Cells of renin lineage are progenitors of podocytes and parietal epithelial cells in experimental glomerular disease","volume":"183","author":"Pippin","year":"2013","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ekir.2020.07.013_bib187","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.semnephrol.2014.06.008","article-title":"Progenitor cells and podocyte regeneration","volume":"34","author":"Shankland","year":"2014","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.ekir.2020.07.013_bib188","first-page":"1109","article-title":"Commonly used mesenchymal stem cell markers and tracking labels:Limitations and challenges","volume":"28","author":"Lin","year":"2013","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.ekir.2020.07.013_bib189","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.molmed.2008.05.005","article-title":"Stem-cell approaches for kidney repair:choosing the right cells","volume":"14","author":"Sagrinati","year":"2008","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.ekir.2020.07.013_bib190","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jcyt.2016.11.003","article-title":"Stem cell therapy: an emerging modality in glomerular diseases","volume":"19","author":"Thakkar","year":"2017","journal-title":"Cytotherapy"},{"key":"10.1016\/j.ekir.2020.07.013_bib191","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1021\/ci100350u","article-title":"LigBuilder 2: a practical de novo drug design approach","volume":"51","author":"Yuan","year":"2011","journal-title":"J\u00a0Chem Inf Model"},{"key":"10.1016\/j.ekir.2020.07.013_bib192","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan3128","article-title":"Repeat doses of antibody to serum amyloid P component clear amyloid deposits in patients with systemic amyloidosis","volume":"10","author":"Richards","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ekir.2020.07.013_bib193","first-page":"3831S","article-title":"Therapeutic potential of chimeric amyloid-reactive monoclonal antibody 11\u20131F4","volume":"9","author":"Solomon","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ekir.2020.07.013_bib194","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3389\/fimmu.2011.00032","article-title":"Generation and characterization of anti-AA amyloid-specific monoclonal antibodies","volume":"2","author":"Wall","year":"2011","journal-title":"Front Immunol"},{"key":"10.1016\/j.ekir.2020.07.013_bib195","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1080\/13506129.2016.1205974","article-title":"2A4 binds soluble and insoluble light chain aggregates from AL amyloidosis patients and promotes clearance of amyloid deposits by phagocytosis (dagger)","volume":"23","author":"Renz","year":"2016","journal-title":"Amyloid"},{"key":"10.1016\/j.ekir.2020.07.013_bib196","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052686","article-title":"AL amyloid imaging and therapy with a monoclonal antibody to a cryptic epitope on amyloid fibrils","volume":"7","author":"Wall","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ekir.2020.07.013_bib197","first-page":"912","article-title":"Established human mesenchymal stem cell lines stably secreting matrix metallopeptidase 7 to treat glomerulosclerosis in light chain deposition disease. Proceedings of the Kidney Week 2019, Washington DC","volume":"30","author":"Feng","year":"2019","journal-title":"J Am Soc Nephrol"},{"issue":"suppl 2","key":"10.1016\/j.ekir.2020.07.013_bib198","first-page":"15","article-title":"Epigallocatechin-3-gallate inhibits renal light chain amyloidogenesis by two different mechanisms. Proceedings of the USCAP 108th Annual Meeting, 2019, National Harbor, MD","volume":"32","author":"Herrera","year":"2019","journal-title":"Modern Pathol"},{"key":"10.1016\/j.ekir.2020.07.013_bib199","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11886-020-1252-3","article-title":"Harnessing cardiac regeneration as a potential therapeutic strategy for AL cardiac amyloidosis","volume":"22","author":"Joshi","year":"2020","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.ekir.2020.07.013_bib200","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000314795","article-title":"Renal amyloidosis:current views on pathogenesis and impact on diagnosis","volume":"169","author":"Herrera","year":"2011","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.ekir.2020.07.013_bib201","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/BF00496558","article-title":"Early glomerular lesions in amyloidosis. Electronmicroscopic findings","volume":"390","author":"von Gise","year":"1981","journal-title":"Virchows Arch A Pathol Anat Histol"},{"key":"10.1016\/j.ekir.2020.07.013_bib202","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/scrt472","article-title":"Mesenchymal stem cell treatment for chronic renal failure","volume":"5","author":"Eirin","year":"2014","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.ekir.2020.07.013_bib203","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/ki.1994.24","article-title":"Tenascin is an important component of the glomerular extracellular matrix in\u00a0normal and pathologic conditions","volume":"45","author":"Truong","year":"1994","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2020.07.013_bib204","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nrm3371","article-title":"Stem cells assessed","volume":"13","author":"Blanpain","year":"2012","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.ekir.2020.07.013_bib205","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1681\/ASN.2010010048","article-title":"Glomerular epithelial stem cells: the good, the bad, and the ugly","volume":"21","author":"Lasagni","year":"2010","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2020.07.013_bib206","doi-asserted-by":"crossref","first-page":"34842","DOI":"10.1038\/srep34842","article-title":"Mesenchymal stem cell therapy ameliorates diabetic nephropathy via the paracrine effect of renal trophic factors including exosomes","volume":"6","author":"Nagaishi","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.ekir.2020.07.013_bib207","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1681\/ASN.2010050559","article-title":"Stem cell therapy for the kidney: a cautionary tale","volume":"21","author":"Nagy","year":"2010","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2020.07.013_bib208","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41581-018-0023-5","article-title":"Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases","volume":"14","author":"Shi","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ekir.2020.07.013_bib209","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1681\/ASN.2005080815","article-title":"Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis","volume":"17","author":"Kunter","year":"2006","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2020.07.013_bib210","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jbiomech.2009.09.009","article-title":"Intrinsic extracellular matrix properties regulate stem cell differentiation","volume":"43","author":"Reilly","year":"2010","journal-title":"J\u00a0Biomech"},{"key":"10.1016\/j.ekir.2020.07.013_bib211","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1080\/01913120490515595","article-title":"Ultrastructure of human embryonic stem cells and spontaneous and retinoic acid-induced differentiating cells","volume":"28","author":"Park","year":"2004","journal-title":"Ultrastruct Pathol"},{"key":"10.1016\/j.ekir.2020.07.013_bib212","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lfs.2014.08.016","article-title":"Curcumin as a wound healing agent","volume":"116","author":"Akbik","year":"2014","journal-title":"Life Sci"},{"key":"10.1016\/j.ekir.2020.07.013_bib213","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s00403-010-1075-y","article-title":"Suppression of TGF-beta1\/SMAD pathway and extracellular matrix production in primary keloid fibroblasts by curcuminoids:its potential therapeutic use in the chemoprevention of keloid","volume":"302","author":"Hsu","year":"2010","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.ekir.2020.07.013_bib214","first-page":"4361","article-title":"Curcumin-induced cell cycle arrest and apoptosis in human acute promyelocytic leukemia HL-60 cells via MMP changes and caspase-3 activation","volume":"26","author":"Tan","year":"2006","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ekir.2020.07.013_bib215","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/biof.1078","article-title":"Skin regenerative potentials of curcumin","volume":"39","author":"Thangapazham","year":"2013","journal-title":"Biofactors"},{"key":"10.1016\/j.ekir.2020.07.013_bib216","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/med.21532","article-title":"Targeting strategies for drug delivery to the kidney: from renal glomeruli to tubules","volume":"39","author":"Liu","year":"2019","journal-title":"Med Res Rev"}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024920313784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024920313784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:47:16Z","timestamp":1778892436000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468024920313784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":216,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S2468024920313784"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2020.07.013","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Understanding Mesangial Pathobiology in AL-Amyloidosis and Monoclonal Ig Light Chain Deposition Disease","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2020.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}